Onconetix, Inc. Depreciation
Onconetix, Inc. (ONCO) reported Depreciation of $15.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-13
- Onconetix, Inc. depreciation for the quarter ending 2023-12-31 was $2.11K, a 14.52% increase year-over-year.
- Onconetix, Inc. depreciation for the quarter ending 2023-09-30 was $1.62K, a 12.36% decline year-over-year.
- Onconetix, Inc. depreciation for the quarter ending 2023-06-30 was $1.57K, a 10.79% decline year-over-year.
- Onconetix, Inc. depreciation for the quarter ending 2023-03-31 was $1.70K, a 30.62% increase year-over-year.
- Onconetix, Inc. depreciation for fiscal 2025 was $15.00K, a 31.82% decline from fiscal 2024.
- Onconetix, Inc. depreciation for fiscal 2024 was $22.00K, a 214.29% increase from fiscal 2023.
- Onconetix, Inc. depreciation for fiscal 2023 was $7.00K, a 3.67% increase from fiscal 2022.
- Onconetix, Inc. depreciation for fiscal 2022 was $6.75K, a 38.08% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2025-12-31 | $15.00K 10-K · filed 2026-03-13 | |||
| 2024-12-31 | $22.00K 10-K · filed 2026-03-13 | |||
| 2023-12-31 | $2.11K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | $3.73K derived: sum of 2 quarters · filed 2025-06-02 | $5.30K derived: sum of 3 quarters · filed 2025-06-02 | $7.00K 10-K · filed 2025-06-02 |
| 2023-09-30 | $1.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $3.19K derived: sum of 2 quarters · filed 2023-11-17 | $4.89K 10-Q · filed 2023-11-17 | $6.73K derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | $1.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | $3.27K 10-Q · filed 2023-10-20 | $5.12K derived: sum of 3 quarters · filed 2023-10-20 | $6.96K derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-03-31 | $1.70K 10-Q · filed 2023-05-12 | $3.54K derived: sum of 2 quarters · filed 2023-05-12 | $5.39K derived: sum of 3 quarters · filed 2023-11-17 | $7.15K derived: sum of 4 quarters · filed 2023-11-17 |
| 2022-12-31 | $1.85K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $3.69K derived: sum of 2 quarters · filed 2023-11-17 | $5.45K derived: sum of 3 quarters · filed 2023-11-17 | $6.75K 10-K · filed 2023-03-09 |
| 2022-09-30 | $1.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $3.61K derived: sum of 2 quarters · filed 2023-11-17 | $4.91K 10-Q · filed 2023-11-17 | $6.06K derived: sum of 4 quarters · filed 2023-11-17 |
| 2022-06-30 | $1.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | $3.06K 10-Q · filed 2023-10-20 | $4.21K derived: sum of 3 quarters · filed 2023-10-20 | $5.47K derived: sum of 4 quarters · filed 2023-10-20 |
| 2022-03-31 | $1.30K 10-Q · filed 2023-05-12 | $2.45K derived: sum of 2 quarters · filed 2023-05-12 | $3.71K derived: sum of 3 quarters · filed 2023-05-12 | $4.96K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $1.15K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.41K derived: sum of 2 quarters · filed 2023-03-09 | $3.66K derived: sum of 3 quarters · filed 2023-03-09 | $4.89K 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.50K derived: sum of 2 quarters · filed 2022-11-14 | $3.74K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.48K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $1.23K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |